Lv61
3160 积分 2021-08-10 加入
Cyclic Peptidesin Modern Drug Discovery: Trends andTherapeutic Directions
6天前
已完结
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer
6天前
已完结
Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRAS G12D Inhibitor
3个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
4个月前
已完结
Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer
5个月前
已完结
New limits proposed for the management of non-mutagenic impurities
5个月前
已完结
TIGIT regulates CD4+ T cell immunity against polymicrobial sepsis
5个月前
已完结
Kras G12C– and G12D–driven lung cancers differ in oncogenic potency, immunogenicity, and relapse after Kras inhibition in mouse models
6个月前
已完结
LBA84 Efficacy and safety of GFH375 monotherapy in previously treated advanced KRAS G12D-mutant pancreatic ductal adenocarcinoma (PDAC)
9个月前
已关闭
皖公网安备34019202002308
